Facioscapulohumeral Muscular Dystrophy

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Quantitative Assessment of Orofacial Muscle Function in FSHD

BetterLife FSHD: A Patient-driven Health and Research Platform

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Biomarker Development for Muscular Dystrophies

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

Personalized Training for People With Rare Neuromuscular Disorders

The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics

Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia)

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Study of Testosterone and rHGH in FSHD